Treatment with liraglutide effectively alleviated central sensitization associated with CM [94] (Fig
Disease-specific quality of life: the Gallstone Impact Checklist
FDA Issues 30 Warning Letters to Telehealth Firms Over Misleading Compounded GLP-1 Marketing Stephen Appezzato Key Takeaways Thirty telehealth firms received warning letters for illegal promotion of compounded semaglutide/tirzepatide, reflecting an expanded enforcement tempo that now surpasses the prior decades letter volume
No bending over, straining, or lifting more than 10 lbs for the first week after surgery
[4] [5] [8] Cagrilintide is a single-pathway amylin analog that remains investigational not approved for any indication anywhere and whose strongest human data come from a fixed combination with semaglutide, not from cagrilintide alone
2025 and 2026 Case Reports Case reports describe the diagnosis, treatment, and follow-up of an individual patient